(S)-1-(4-(4-METHYLTHIAZOL-5-YL)PHENYL)ETHAN-1-AMINE HCL, 95.0%, 10g

6-(DIFLUOROMETHYL)-1H-INDAZOLE, 95%, 500mg

4-Amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxybenzamide hydrochloride hydrate, 95.0%, 25g

2-Bromo-4,5-dimethylphenylboronic acid, 98%, 1g

Béchers à échantillons avec couvercle à clipser, non stérile, 500 pièce(s), Couvercle bleu, plat

3,3-dimethyl-1-(3-pyridinyl)-1-butanamine, 95.0%, 10g

2-(2,4-Dichlorophenoxy)ethan-1-amine, 98%, 1g

ETHYL 8-BENZYL-3-OXO-1-OXA-8-AZASPIRO[4.5]DECANE-4-CARBOXYLATE, 95.0%, 250mg

Neocuproine hydrochloride hydrate, 99.0%, 25g

4-Vinylbenzenesulfonamide, 97% mix TBC as stabilizer, 250mg

Methyl 2-fluoroacrylate (stabilised with 1% BHT), 96.0%, 10g

(R)-tert-Butyl 2-amino-3-(3-bromophenyl)propanoate, 95.0%, 250mg

3-chloro-4-{[5-(trifluoromethyl)pyridin-2-yl]oxy}aniline, 1g